title: The role of melatonin in patients with chronic kidney disease undergoing haemodialysis.
abstract: Patients with chronic kidney disease including those undergoing haemodialysis have deranged sleep-wake pattern. In large part this is due to an abnormal circadian cycle of melatonin, a hormone secreted by the pineal gland in the evening and induces sleep. Subjects undergoing automated peritoneal dialysis or nocturnal haemodialysis have better sleep profile compared to those on daytime dialysis. Studies have shown that exogenous melatonin improves sleep-wake cycle in daytime haemodialysis patients. However, large randomised controlled trials are needed in order to establish its role in this patient population.
authors.affiliation: Nephrology Department, General Hospital of Rhodes, Agioi Apostoloi, Rhodes, Greece. gaperis@yahoo.com
authors.forename: Georgios
authors.initials: G
authors.lastname: Aperis
authors.forename: Preeth
authors.initials: P
authors.lastname: Prakash
authors.forename: Christos
authors.initials: C
authors.lastname: Paliouras
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Papakonstantinou
authors.forename: Polichronis
authors.initials: P
authors.lastname: Alivanis
mesh_terms: D002940:Circadian Rhythm / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy / Q000451:nursing*; D008550:Melatonin / Q000097:blood* / Q000627:therapeutic use; D006435:Renal Dialysis / Q000451:nursing*; D020178:Sleep Disorders, Circadian Rhythm / Q000097:blood / Q000188:drug therapy / Q000451:nursing*
chemical_list: D008550:Melatonin